Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study-Reference-Cited by-同舟云学术

Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study

Published:2015-11-10 Issue:11 Volume:113 Page:1622-1631
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Bešević Jelena,Gunter Marc J,Fortner Renée T,Tsilidis Konstantinos K,Weiderpass Elisabete,Charlotte Onland-Moret N,Dossus Laure,Tjønneland Anne,Hansen Louise,Overvad Kim,Mesrine Sylvie,Baglietto Laura,Clavel-Chapelon Françoise,Kaaks Rudolf,Aleksandrova Krasimira,Boeing Heiner,Trichopoulou Antonia,Lagiou Pagona,Bamia Christina,Masala Giovanna,Agnoli Claudia,Tumino Rosario,Ricceri Fulvio,Panico Salvatore,Bueno-de-Mesquita HB(as),Peeters Petra H,Jareid Mie,Ramón Quirós J,Duell Eric J,Sánchez María-José,Larrañaga Nerea,Chirlaque María-Dolores,Barricarte Aurelio,Dias Joana A,Sonestedt Emily,Idahl Annika,Lundin Eva,Wareham Nicholas J,Khaw Kay-Tee,Travis Ruth C,Rinaldi Sabina,Romieu Isabelle,Riboli Elio,Merritt Melissa A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2015377.pdf

Reference31 articles.

1. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Silva Azevedo E, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP (2014) Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385 (9972): 977–1010.

2. Beral V, Doll R, Hermon C, Peto R, Reeves G (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371 (9609): 303–314.

3. Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385 (9980): 1835–1842.

4. Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71 (4): 717–721.

5. Cunat S, Hoffmann P, Pujol P (2004) Estrogens and epithelial ovarian cancer. Gynecol Oncol 94 (1): 25–32.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in Australia;International Journal of Cancer;2024-09-02

2. Supportive care of female hormones in brain health: what and how?;Frontiers in Pharmacology;2024-07-24

3. Prediagnostic use of menopausal hormone therapy and long‐term survival of localized epithelial ovarian cancer: The Extreme study;International Journal of Cancer;2024-03-26

4. Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review;Journal of Clinical Medicine;2024-03-01

5. Nutrients-Rich Food Index Scores and the Overall Survival of Ovarian Cancer Patients: Results from the Ovarian Cancer Follow-Up Study, a Prospective Cohort Study;Nutrients;2023-01-31